The transition from Angel to institutional funding is a key step (but not quite an absolute requirement) in the evolution of a start-up bringing a new device to market. Broadening investments accompany deepening organizational sophistication, as start-ups more and more take on the business and regulatory trappings of larger device companies. However, even the best medical devices proposed by the best founding teams must cross the most critical governing threshold before reaching the market.
Image: https://medium.com
{iframe}https://medium.com/bioeconomy-xyz/where-new-medical-devices-come-from-132ffd7836ff{/iframe}